Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab (ERASER)
Performance assessment testing may be a useful tool to evaluate the impact of ranibizumab on day-to-day visual function in patients with Diabetic Macular Edema (DME).